A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab
Clinical trial NCT04365387 · COMPLETED
Trial details
- NCT number
- NCT04365387
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2023-07-07
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.